Among the NTRs, there was a borderline significant difference (two-tailed independent t -test, p = 0.053, n = 6) in the level of p75NTR expression in the MOE with a higher level in vehicle-exposed TRPM5-GFP than in Skn-1a −/− mice, implying that TRPM5-MCs might, to some degree, modulate p75NTR expression.
← all phrases
“borderline significant”
Sighted at
p=0.09
In the literature
PA and PROMs in Cross-Sectional Analysis At baseline, patients performing high PA reported fewer occurrences of liquid/soft stools compared to those with low PA, with a borderline significant difference (median 0 [0–1] vs. 0 [0–2], p = 0.053).
barbatula was smaller after the gypsum treatment (Table 3 ), but the difference was only borderline significant ( t = −4.2; df = 2; p = 0.053).
There is a positive correlation (ρ = 0.31) between Citrate and percentage area of lumen, however after correcting for multiple testing, it is only borderline significant at the 0.05 level ( p = 0.053).
High PD-1 expression was significantly associated with a prolonged OS in gastric cancer ( p = 0.041), whereas a borderline significant association was observed between high PD-1 expression and a shorter OS ( p = 0.053) in esophageal cancer.
Predictors of LVEDV in subjects with a normal LVEF In subjects with a LVEF ≥55% (n = 84), LVEDV was positively correlated with BSA (r = 0.76, p<0.001) and was higher in males (p<0.001), but male sex was only a borderline significant predictor of LVEDV after adjusting for BSA (p = 0.053).
When the model was further adjusted (Model 3), the difference in physical functioning was only borderline significant (mean difference −4.9 [95% CI −9.9 to 0], P = .053).
In contrast, the KSS group demonstrated a non-significant mean eGFR improvement of 2.88 ± 19.20 ml/min/1.73 m2 (P = 0.426) and a borderline significant mean creatinine decrease of 8.69 ± 23.11 μmol/L (P = 0.053).
The decrease at 15 Gy relative to 5 and 10 Gy analysed together was significant (or borderline significant) for both breast cancer cell lines (P = 0.053 and 0.007, respectively).
The association between LV mass/LV end-diastolic volume and incident CVD was borderline significant ( P =0.053).
There was borderline significant difference in virological relapse rate was detected between the entecavir and TAF groups ( P = 0.053, Fig. 1 A).
The analysis also showed a borderline significant main effect of Sector, F(1, 100) = 3.84, p = .053, η p 2 = .04 (S), with military commanders achieving slightly higher ratings than police commanders.
After consistent trials, the conflict effect was slightly greater in the left brain region than in the right, with a borderline significant difference ( p = 0.053).
There was a borderline significant reduction of insulin levels immediately following the cessation of exercise in the Low-intensity group ( P = 0.053), although they were no different from baseline 30 minutes following the cessation of exercise ( P = 1.0).
The incidence of HCC tend to be lower in the antiviral group, and the difference was borderline significant ( P =0.053).
An a priori ROI analysis revealed significant activation in the left primary auditory cortex (−60–31 20, k = 12, T[140] = 4.03, P = 0.03) and borderline significant effect in the right primary auditory cortex (54–13 11, k = 5, T[140] = 3.51, P = 0.053).
This difference was borderline significant, p=0.053.
Borderline significant differences were also seen on the delayed recall item when category cues were provided ( χ 2 (2) = 5.886, p = 0.053).
The association between multiorgan metastases and PFS remained borderline significant (HR: 3.80; 95% CI: 0.98–14.80; p = 0.053) ( Table 4 ).
When we ran the meta-regression on the total number of exposure categories, there was a borderline significant association ( P = 0.053); however, the number of studies in each strata was few.
This analysis, shown in Supplementary Table 3 , did not change the HR of the covariates and all covariates were significant, except for multifocal disease which was borderline significant (p = 0.053) and biopsy vs. resection which showed no association (p = 0.13).
Change in VCTE In the random effects model assessing change in VCTE, FGF21 demonstrated a significant standardized mean difference (SMD) of −1.71 (95% CI: −3.11 to −0.31, p = 0.017) compared to placebo, while Resmetirom showed a borderline significant effect with an SMD of −1.68 (95% CI: −3.38 to 0.02, p = 0.053) ( Figure 4 ).
19 However, a similar study of 23 European countries found a correlation between government funded influenza vaccination programs and country level vaccination rates, though the finding was only borderline significant (r = 0.43, p = .053). 20 Copay programs Co-payment (fixed amount paid by the patient out-of-pocket after their deductible is paid) policies were found to have mixed results on VCRs.
In contrast, studies with 4 to <7 sessions showed a smaller, borderline significant effect (SMD = −0.43, 95% CI: −0.86 to 0.01, p = 0.053) and higher heterogeneity ( I 2 = 76.4%).
There was also a significant linear effect of block, F (1, 30) = 33.09, p < .0001, η p 2 = .524, and a borderline significant interaction of validity with block, F (4, 120) = 4.34, p = .053, η p 2 = .074 (see Figure 10 ).